Arkolith/Insider Trading/MAZE/Form 4

Bachrodt Amy

SVP, FinanceMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$74K
Net Open-Market Flow
-$74K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)3K$10.42$26K15K
Apr 1, 2026Sell(S)2K$29.32$65K13K
Apr 1, 2026Sell(S)300$30.34$9K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)3K—$034K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050422-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML